#Drug Discovery

XPRIZE Quantum Applications: Finalists Push Real-World Quantum

Generative Antibody Design Cracks 'Undruggable' Targets

Onepot AI Secures $13 Million to Revolutionize Chemical Synthesis for Drug Discovery

The AI-Driven Future of Biotech: Insights from Benchling's CEO

Lilly Blackwell Drug Discovery: A New Era

Tahoe-x1 single cell model scales AI for cancer drug discovery

Google's AI Tools Advance Cancer Fight

AI Cancer Breakthrough: Gemma Model Uncovers New Therapy

Salt AI Raises $10M to Advance Contextual AI in Life Sciences

Biotech's AI Infusion: A Tremendous Opportunity

Virtual Cells: Unlocking Biology's Latent Speed with AI

Enveda Secures $150M Series D, Achieves Unicorn Status

Treeline Biosciences Raises $200M, Initiates Clinical Trials

The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.

Tahoe Therapeutics Raises $30M for AI Human Cell Models

Tahoe Therapeutics secured $30 million in new funding. Amplify Partners led the round. This capital will fuel the creation of AI models of human cells to advance drug discovery.

Latvian Cellbox Labs Lands €3.3M for Organ-on-Chip Innovation

Latvian Cellbox Labs secured €3.3 million in non-dilutive funding. This capital, partly from the IPCEI “Tech4Cure” initiative, supports its organ-on-chip technology development. The investment aims to advance drug discovery and reduce reliance on animal testing.

SNIPR Biome Secures €35M Series B for CRISPR Therapies

SNIPR Biome, a Danish biotech, secured €35 million in Series B funding. New investors Cystic Fibrosis Foundation and SPRIN-D joined the round, alongside existing backers. This capital will advance its microbial CRISPR-medicine development, including therapies for cystic fibrosis and antimicrobial resistance.

SNIPR Biome Secures €35M Series B for CRISPR Therapies

Copenhagen-based SNIPR Biome , a Danish biotech scale-up, secured €35 million in Series B funding.

AI's Amplifying Force in Scientific Discovery: The AlphaFold Breakthrough

Investors Eye Quantum as the Next AI Frontier

Vivodyne Secures $40 Million to Revolutionize Drug Discovery

John Snow Labs Acquires WiseCube to Refine and Safeguard Medical AI Models with Knowledge Graphs

PharmAla Biotech Launches Phenesafe AI Drug Discovery Platform for Novel Phenethylamines

IAG Capital Partners Leads $24M in Generative AI Startup for Drug Discovery, DeepCure

9xchange and BenevolentAI Announce Strategic Partnership on Biopharma Asset Marketplace

DeepCure Closes $40 million Series A Funding Led by Morningside Ventures

Series A financing will catalyze growth and advance novel small molecule therapeutics pipeline across various disease indications. The funding will also be used to build an automated robotic wet lab to complete DeepCure’s vision of end-to-end AI drug discovery